study,trt,class,mean,sd,se,n
allen 2014,placebo,placebo,3.13,1.13,0.12961989,76
allen 2014,desvenlafaxine standard,snri,2.74,1.1,0.14969104,54
allen 2014,desvenlafaxine high,snri,2.71,1.09,0.130279918,70
allen 2014,desvenlafaxine high,snri,2.35,1.08,0.130016721,69
allen 2014,desvenlafaxine high,snri,2.52,1.07,0.159506182,45
arnold 2004,placebo,placebo,3.53,1.69,0.169851391,99
arnold 2004,duloxetine high,snri,3.02,1.66,0.170312406,95
arnold 2005,placebo,placebo,3.71,1.5,0.142373699,111
arnold 2005,duloxetine standard,snri,3.11,1.77,0.165775689,114
arnold 2005,duloxetine high,snri,3.06,1.73,0.164204333,111
arnold 2010: 3,placebo,placebo,3.36,1.44,0.090176298,255
arnold 2010: 3,duloxetine high,snri,2.79,1.57,0.100303621,245
arnold 2012: 1,placebo,placebo,3.35,1.48,0.119650908,153
arnold 2012: 1,duloxetine low,snri,2.97,1.48,0.119650908,153
chappell 2008,placebo,placebo,3.72,1.54,0.119888837,165
chappell 2008,duloxetine high,snri,3.43,1.63,0.129675837,158
chappell 2009: 1,duloxetine standard,snri,2.19,1.53,0.150028843,104
chappell 2009: 1,duloxetine high,snri,2.65,1.57,0.110192398,203
chappell 2009: 2,placebo,placebo,2.91,1.28,0.119882984,114
chappell 2009: 2,duloxetine high,snri,2.38,1.22,0.119630842,104
chappell 2011,placebo,placebo,3.07,1.13,0.099878833,128
chappell 2011,duloxetine high,snri,2.77,1.24,0.109601551,128
enomoto 2018,pregabalin ,nonad,2.6,1.22,0.099946294,149
enomoto 2018,duloxetine low,snri,2.4,1.23,0.099766174,152
gao 2010,placebo,placebo,2.64,1.04,0.099613934,109
gao 2010,duloxetine high,snri,2.32,1.13,0.109755302,106
gao 2015,placebo,placebo,2.65,0.93,0.070101388,176
gao 2015,duloxetine standard,snri,2.44,0.92,0.069946305,173
goldstein 2005,placebo,placebo,2.91,1.26,0.119593907,111
goldstein 2005,duloxetine low,snri,2.68,1.25,0.120281306,108
goldstein 2005,duloxetine standard,snri,2.21,1.26,0.119593907,111
goldstein 2005,duloxetine high,snri,2.24,1.25,0.119728286,109
raskin 2005,placebo,placebo,3.04,1.06,0.100160585,112
raskin 2005,duloxetine standard,snri,2.5,1.04,0.099613934,109
raskin 2005,duloxetine high,snri,2.54,1.05,0.09966159,111
rowbotham 2012,placebo,placebo,3,1.43,0.200240052,51
rowbotham 2012,duloxetine standard,snri,2.8,1.51,0.200004386,57
rowbotham 2012,abt-894 ,nonad,2.9,0.78,0.099868766,61
rowbotham 2012,abt-894 ,nonad,3,1.5,0.200445931,56
rowbotham 2012,abt-894 ,nonad,3,1.48,0.199563159,55
russell 2008,placebo,placebo,3.37,1.56,0.13,144
russell 2008,duloxetine standard,snri,2.79,1.51,0.169888273,79
russell 2008,duloxetine standard,snri,3.08,1.59,0.129822956,150
russell 2008,duloxetine high,snri,2.93,1.58,0.130316204,147
shinichi 2016,placebo,placebo,2.76,0.99,0.070003571,200
shinichi 2016,duloxetine standard,snri,2.46,1.01,0.069863161,209
skljarevski 2009,placebo,placebo,2.93,1.39,0.130185428,114
skljarevski 2009,duloxetine low,snri,2.72,1.28,0.169540142,57
skljarevski 2009,duloxetine standard,snri,2.44,1.35,0.129903811,108
skljarevski 2009,duloxetine high,snri,2.66,1.34,0.12954269,107
skljarevski 2010: 1,placebo,placebo,3.23,1.26,0.117495606,115
skljarevski 2010: 1,duloxetine high,snri,2.81,1.18,0.114074906,107
skljarevski 2010: 2,placebo,placebo,3.19,1.27,0.090027913,199
skljarevski 2010: 2,duloxetine standard,snri,2.88,1.25,0.08974477,194
tesfaye 2013,pregabalin ,nonad,2.94,1.43,0.071233374,403
tesfaye 2013,duloxetine standard,snri,2.6,1.12,0.055930131,401
uchio 2018,placebo,placebo,2.84,1.19,0.089699625,176
uchio 2018,duloxetine standard,snri,2.23,1.2,0.090197523,177
wernicke 2006,placebo,placebo,3.17,1.44,0.140529611,105
wernicke 2006,duloxetine standard,snri,2.61,1.44,0.13606721,112
wernicke 2006,duloxetine high,snri,2.4,1.29,0.124709007,107
yasuda 2011,placebo,placebo,3.18,1.54,0.119888837,165
yasuda 2011,duloxetine low,snri,2.53,1.28,0.13965945,84
yasuda 2011,duloxetine standard,snri,2.52,1.29,0.139920145,85